BioStem Technologies, Inc. (BSEM) Gross margin 2024–2025
BioStem Technologies, Inc. (BSEM) gross margin by fiscal year — reported gross profit divided by reported revenue.
93.6%FY2025 · since FY2024: 80.3% → 93.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 93.6% | +13.3 pp |
| FY2024 | 80.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BSEM financial trends
BSEM RevenueBSEM Net incomeBSEM Net marginBSEM Gross profitBSEM Operating incomeBSEM Operating marginBSEM Operating cash flowBSEM Free cash flowBSEM Capital expendituresBSEM Return on equityBSEM Stock buybacksBSEM Dividends paidBSEM Total assetsBSEM Total liabilitiesBSEM Shareholders’ equityBSEM overview →